Comparing the current results to its competitors, Accuray Incorporated reported Revenue decrease in the 4 quarter 2026 year on year by -21.14 %, despite the revenue increase by the most of its competitors of 22.19 %, recorded in the same quarter.
Accuray Incorporated, despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 17.05 %
Accuray Incorporated's Comment on Competition and Industry Peers
The radiation therapy systems market is primarily led by Varian Medical Systems, Inc., a Siemens Healthineers company, and Elekta AB. Both companies produce standard linear accelerator (linac) systems compatible with body and head frame systems and image guidance technologies for radiosurgical and radiotherapy procedures. Other competitors in the market include RefleXion Medical Inc., ZAP® Surgical Systems, Inc., United Imaging Healthcare Co., Ltd., BrainLAB AG, ViewRay Inc., and Zap Medical. Additionally, various government, academic, and business entities are engaged in research and development of cancer treatments, which may influence the relevance of existing products. Some competitors possess greater corporate, financial, operational, sales, marketing resources, and research and development experience, potentially enabling them to develop more effective or commercially viable technologies that could affect the competitiveness of other companies' products.
Concord Medical Services Holdings Ltd Share Performance
-4.61%
Over The Past 5 Days
Concord Medical Services Holdings Ltd
Profile
Concord Medical Services Holdings Ltd operates a network of radiotherapy and diagnostic imaging centers in China. The company partners with hospitals to provide advanced medical technology and expertise, offering comprehensive cancer treatment services to patients. By leveraging their extensive network, Concord Medical aims to improve healthcare accessibility, quality, and affordability across the country.
Edap Tms Sa's business model revolves around providing minimally invasive medical devices and solutions for the treatment of urological diseases, specifically focusing on advanced ultrasound technologies for the diagnosis and treatment of prostate cancer and kidney stones.
Fonar Corporation operates as a medical technology company that specializes in the development, production, and marketing of magnetic resonance imaging (MRI) scanners. Their business model revolves around selling and servicing their proprietary MRI machines to healthcare facilities worldwide. They generate revenue through the sales of these scanners, as well as by providing additional services such as maintenance and support to their customers.
General Electric Companys business model centers on industrial operations, creating and delivering advanced technologies, products, and services across sectors such as power generation, aviation, healthcare, and renewable energy. The company emphasizes innovation and sustainability, aiming to enhance performance and efficiency for customers while tackling pressing societal and environmental issues.
Hyperfine Inc operates on a business model that focuses on designing and manufacturing portable and affordable magnetic resonance imaging (MRI) systems, enabling medical professionals to access advanced imaging technology at a lower cost, expanding the reach of MRI diagnostics.
Sources:
Accuray Incorporated’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Accuray Incorporated versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
